This one is kind of delayed, but researchers in the Baltimore/DC/MD area might find it useful...
Multidrug Resistance and ABC Transporters conference
November 5, 2008 - Baltimore, Maryland USA
Register and submit your abstract today!
Best Western Hotel & Conference Center
5625 O'Donnell Street
Baltimore, Maryland 21224-4630, USA (map)
November 5, 2008
9:00am to 6:00pm
Dr Suresh V. Ambudkar (National Cancer Institute, NIH) and Abcam, Inc.
The meeting will cover multidrug resistance in cancer and ABC transporters: basic, clinical, regulation and drug-drug interaction aspects.
* Invited speakers
* Call for papers
* Sponsorship opportunities
* Contact information
* Keynote: Dr Michael M. Gottesman (National Cancer Institute, NIH)
Current status of multidrug resistance and ABC transporters
* Dr Suresh V. Ambudkar (National Cancer Institute)
Mechanism of action of multidrug resistance-linked ABC drug transporters
* Dr David S. Miller (National Institute of Environmental Health Sciences, NIH)
Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier
* Dr. Robert B. Innis (National Institute of Mental Health, NIH)
Positron emission tomographic imaging of drug efflux transporters
* Dr Gilbert J. Burckart (U.S. Food and Drug Administration)
Drug-drug interactions and regulatory implications for membrane transporter substrates in drug development
* Dr Maria R. Baer (University of Maryland Greenebaum Cancer Center)
Clinical and therapeutic implications of multidrug resistance-associated ABC drug transporters
Additional talks from submitted abstracts:
* Dr. Wilfred Stein (National Cancer Institute, NIH)
Polymorphisms within PfMDR1 alter the substrate specificity for antimalarial drugs in Plasmodium falciparum
* Ms. Maria DeRosa (Hospital for Sick Children)
Inhibition of MDR1 as possible therapy for Fabry Disease
* Dr. Zhe-Sheng (Jason) Chen (St. John's University)
Tyrosine kinase inhibitors as modulators of multidrug resistance in cancer
* Dr. Robert Robey (National Cancer Institute, NIH)
Novel inhibitors of ABCG2 identified by high-throughput screening analysis
* Dr. Demian Park (Phylonix)
Zebrafish: A predictive model for assessing modulators of P-glycoprotein efflux
* Dr. Anne-Marie Bleau (Memorial Slaon-Kettering Cancer Center)
Loss of PTEN increases ABCG2 activity in glioma tumor stem cells and contributes to the MDR phenotype
* Dr. Daotai Nie (Southern Illinois University School of Medicine)
The role of PXR in cancer multidrug resistance
* Dr. Tianyong Zhao (University of Kentucky)
Multidrug resistance-associated protein 1 (MRP1) localizes in junction of cultured HL1 cells and mediates doxorubicin induced stress signal transmission between cells
Stay tuned for additional talk announcements!
Call for papers:
Abstracts for oral presentations and posters which fit within the theme of the meeting are invited. There will be reception during poster session to allow interactions with the experts in the field.
Oral abstract deadline: Extended to August 15, 2008
Poster abstract deadline: October 5, 2008
Posters will be judged. The winner will receive up to $150 off their registration for a future Abcam conference or an antibody from the Abcam catalog.
Posters must be no larger than four feet tall by eight feel wide.
Abstract submission guidelines.PDF
Early Bird: Register by October 5, 2008
Standard: Register after October 5, 2008